Partnering
A Corporate Commitment to Partnership Success
Repligen is actively seeking partnership opportunities across multiple disciplines in both its therapeutic and BioProcessing businesses.
Repligen Therapeutic Partnering Opportunities
Repligen is using its financial resources to fuel a broad pipeline of drug candidates with a focus on neurology, gastroenterology and orphan diseases. In order to expand its therapeutic pipeline, Repligen is actively seeking to acquire proprietary, development-stage therapeutic candidates with well-understood biology in clinical indications such as neurology, psychiatry, gastroenterology or orphan diseases. The company has the clinical and regulatory expertise required to advance small molecules and biologics from lead identification through Phase 3 development.
A key part of Repligen's business strategy is to seek partners for later stage development of clinical candidates that address a large disease indication. The company will seek to partner its orphan disease programs in Friedreich's ataxia and Spinal Muscular Atrophy.
To learn more about Repligen's partnering opportunities, please contact the company.
Repligen BioProcessing Partnering Opportunities
Repligen BioProcessing is first and foremost a protein manufacturing company. In addition to this core capability we have built a highly specialized biotechnology and life sciences R&D group, a set of flexible business practices and commercialization channels that can support direct to end user customer sales or OEM supply.
We are routinely engaged in partnerships that leverage all our expertise from contract or co-development programs in protein based research and development, fermentation, purification and commercialization.
Repligen BioProcessing is continuously looking for new partnership opportunities where we can leverage:
- Our manufacturing and R&D expertise as an OEM development and manufacturing partner
- Our commercial and financial strengths to create commercial alliances through acquisition, license or co-marketing agreements.
Do you have an idea, proposal or just a question for BioProcessing Partnering? If so, please contact Steve Tingley, stingley@repligen.com.